U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07213310) titled 'Drug-Drug Interaction Study to Evaluate the Effect of DWC202511 or DWC202512 With DWP16001 in Healthy Adults' on July 29.
Brief Summary: Drug-Drug Interaction Study to Evaluate the Effect of DWC202511 or DWC202512 With DWP16001 in Healthy Adults
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: DWP16001
Tablets, Oral
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Daewoong Pharmaceutical Co. LTD.
Disclaimer: Curated by HT Syndication....